CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 208 filers reported holding CONMED CORP in Q4 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $634,587 | +33.3% | 7,180 | +23.8% | 0.00% | 0.0% |
| Q3 2022 | $476,000 | -59.6% | 5,801 | -26.3% | 0.00% | 0.0% |
| Q1 2022 | $1,179,000 | +180.0% | 7,868 | +164.8% | 0.00% | – |
| Q4 2021 | $421,000 | -14.8% | 2,971 | -20.9% | 0.00% | – |
| Q3 2021 | $494,000 | -7.3% | 3,758 | -4.3% | 0.00% | -100.0% |
| Q2 2021 | $533,000 | -44.9% | 3,926 | -46.3% | 0.00% | 0.0% |
| Q1 2021 | $968,000 | +22.5% | 7,306 | +3.5% | 0.00% | 0.0% |
| Q4 2020 | $790,000 | +1.3% | 7,062 | +0.8% | 0.00% | 0.0% |
| Q4 2019 | $780,000 | +87.1% | 7,006 | +61.9% | 0.00% | 0.0% |
| Q3 2019 | $417,000 | +56.8% | 4,328 | +39.5% | 0.00% | 0.0% |
| Q2 2019 | $266,000 | -90.2% | 3,102 | -90.5% | 0.00% | -80.0% |
| Q1 2019 | $2,727,000 | -34.9% | 32,774 | -49.8% | 0.01% | -37.5% |
| Q4 2018 | $4,187,000 | +211.3% | 65,227 | +207.1% | 0.01% | +300.0% |
| Q1 2018 | $1,345,000 | +320.3% | 21,238 | +193.0% | 0.00% | +100.0% |
| Q4 2016 | $320,000 | – | 7,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 1,385,000 | $58,862,000 | 5.19% |
| SIGNIA CAPITAL MANAGEMENT LLC | 146,589 | $6,230,000 | 2.32% |
| HEARTLAND ADVISORS INC | 1,773,782 | $75,386,000 | 1.31% |
| NORTH TIDE CAPITAL, LLC | 350,000 | $14,875,000 | 1.30% |
| Aurora Investment Counsel | 38,196 | $1,623,000 | 1.07% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 571,150 | $24,274,000 | 0.99% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 102,500 | $4,356,000 | 0.90% |
| Tributary Capital Management, LLC | 98,862 | $4,202,000 | 0.83% |
| PERKINS CAPITAL MANAGEMENT INC | 27,850 | $1,184,000 | 0.80% |
| Iguana Healthcare Management, LLC | 25,000 | $1,063,000 | 0.61% |